Belite Bio, Inc
BLTE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,880 | $2,125 | $1,985 |
| - Cash | – | $0 | $0 | $32 |
| + Debt | – | $0 | $0 | $1 |
| Enterprise Value | – | $1,880 | $2,125 | $1,954 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$22 | -$16 | -$15 | -$8 |
| % Margin | – | – | – | – |
| Net Income | -$22 | -$16 | -$14 | -$10 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.65 | -0.5 | -0.44 | -0.32 |
| % Growth | -30% | -13.6% | -37.5% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |